Co-Authors
This is a "connection" page, showing publications co-authored by Holger Rabenau and Niko Kohmer.
Connection Strength
3.936
-
Utility of Different Surrogate Enzyme-Linked Immunosorbent Assays (sELISAs) for Detection of SARS-CoV-2 Neutralizing Antibodies. J Clin Med. 2021 May 14; 10(10).
Score: 0.945
-
The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro. J Clin Med. 2021 Jan 17; 10(2).
Score: 0.924
-
Clinical performance of different SARS-CoV-2 IgG antibody tests. J Med Virol. 2020 10; 92(10):2243-2247.
Score: 0.888
-
Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays. J Clin Virol. 2020 08; 129:104480.
Score: 0.885
-
Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs). J Virol Methods. 2021 05; 291:114102.
Score: 0.232
-
Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro. J Infect Dis. 2021 10 13; 224(7):1109-1114.
Score: 0.061